Osteoblast function and osteomalacia in metastatic prostate cancer

Area of Science:

• Oncology
• Bone Biology
• Pathology

Background:

• Prostate cancer commonly metastasizes to bone, affecting skeletal integrity.
• The interplay between prostate cancer and bone metabolism, particularly osteoblast function, requires further elucidation.
• Understanding these effects is crucial for managing skeletal-related events in advanced prostate cancer.

Purpose of the Study:

• To investigate the impact of prostate cancer on bone matrix formation and mineralization by osteoblasts.
• To assess the relationship between prostate cancer bone metastases and osteomalacia.
• To compare histomorphometric parameters in tumor-free bone, peritumoral bone, and bone infiltrated by prostate cancer.

Main Methods:

• Transiliac bone biopsy in 67 patients with prostatic bone metastases.
• Double tetracycline labeling for assessing bone mineralization.
• Histomorphometric analysis of bone areas distant from, local to, and infiltrated by prostate cancer.

Main Results:

• Bone matrix formation and corrected mineral apposition rate were reduced in tumor-free and peritumoral bone.
• Osteoid surface, osteoid volume, and mineral apposition rate were significantly increased within metastatic bone (p < 0.0001).
• Osteoblast function was disturbed in both metastatic and tumor-free bone areas, but classical osteomalacia was not observed.

Conclusions:

• Prostate cancer bone metastases are associated with a high bone turnover state.
• Osteoblast dysfunction occurs in the presence of prostate cancer, affecting bone remodeling.
• Classical osteomalacia is not a characteristic feature of prostate cancer bone involvement.